Bruker Corporation Appoints Dr. Gilles Martin to its Board of Directors
News Jan 20, 2014
Bruker Corporation has announced the election of Dr. Gilles Martin to its Board of Directors.
Dr. Martin is Chairman and Chief Executive Officer of the Eurofins Scientific Group, a Luxembourg-based international life-sciences company which provides a range of analytical testing services to clients across multiple industries.
Dr. Martin founded the original Eurofins Scientific Nantes food authenticity laboratory in 1988 and is a past President of the French Association of private analytical laboratories, and the North American Technical Committee for Juice and Juice Products. Dr. Martin holds a Ph.D. in Statistics and Applied Mathematics and a Master of Science from Syracuse University.
Frank Laukien, Bruker’s President and CEO, stated: “It is my great pleasure to welcome Gilles Martin to the Bruker Board of Directors as an independent director. I believe that Gilles will contribute strongly to the Bruker Board due to his tremendous entrepreneurial accomplishments at Eurofins, and with his in-depth knowledge of the environmental testing, food safety analysis and pharma CRO markets.”
Dr. Martin commented: “I am very excited to join the Board of Bruker, as the Company is expanding in the applied markets where I have extensive experience based upon my work at Eurofins. I hope that my general business and specific industry expertise, combined with the good work already being done by Bruker in the applied and CRO markets, can contribute to further profitable growth and the creation of shareholder value at Bruker.”
Ingestible Drug-Delivery Materials May Improve Patient Treatment ComplianceNews
Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.READ MORE
Steaming Fish Eliminates More Cyanotoxins Than BoilingNews
Utilizing UHPLC researchers have shown that steaming freshwater fish for more than two minutes reduces the presence of the cyanotoxin, cylindrospermopsin, by up to 26% compared to 18% for boiling.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Comments | 0 ADD COMMENT
International Conference and Exhibition on Nanomedicine and Nanotechnology
Nov 23 - Nov 24, 2017